- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/10 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 263/10
Total number of patents in this class: 41
10-year publication summary
|
2
|
4
|
0
|
3
|
2
|
2
|
2
|
2
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nippon Soda Co., Ltd. | 891 |
4 |
| Epitech Group S.r.l. | 22 |
3 |
| Masteam Bio-Tech Co. Ltd. | 2 |
2 |
| Nankai University | 239 |
2 |
| Zhejiang University of Technology | 262 |
2 |
| Grey Wolf Therapeutics Limited | 16 |
2 |
| BASF SE | 21053 |
1 |
| The Regents of the University of California | 20172 |
1 |
| Evonik Degussa GmbH | 1478 |
1 |
| Massachusetts Institute of Technology | 10127 |
1 |
| Sumitomo Chemical Company, Limited | 9090 |
1 |
| Abbvie Inc. | 1802 |
1 |
| The Board of Trustees of the University of Illinois | 2705 |
1 |
| Arena Pharmaceuticals, Inc. | 362 |
1 |
| Cocrystal Pharma, Inc. | 46 |
1 |
| Coyote Pharmaceuticals, Inc. | 12 |
1 |
| Infineum International Limited | 413 |
1 |
| Mylan Laboratories Limited | 177 |
1 |
| Peking University | 1333 |
1 |
| The Scripps Research Institute | 1353 |
1 |
| Other owners | 12 |